Report Detail
Global (United States, European Union and China) Ponatinib Market Research Report 2019-2025
- RnM3650160 |
- 06 August, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Ponatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL).
In 2019, the market size of Ponatinib is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Ponatinib.
This report studies the global market size of Ponatinib, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Ponatinib sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
ARIAD Pharmaceuticals
...
Market Segment by Product Type
45mg
15mg
Market Segment by Application
CML
ALL
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Ponatinib status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Ponatinib manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Ponatinib are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Ponatinib Market Size Growth Rate by Type (2019-2025)
- 1.3.2 45mg
- 1.3.3 15mg
- 1.4 Market Segment by Application
- 1.4.1 Global Ponatinib Market Share by Application (2019-2025)
- 1.4.2 CML
- 1.4.3 ALL
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Ponatinib Market Size
- 2.1.1 Global Ponatinib Revenue 2014-2025
- 2.1.2 Global Ponatinib Sales 2014-2025
- 2.2 Ponatinib Growth Rate by Regions
- 2.2.1 Global Ponatinib Sales by Regions 2014-2019
- 2.2.2 Global Ponatinib Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Ponatinib Sales by Manufacturers
- 3.1.1 Ponatinib Sales by Manufacturers 2014-2019
- 3.1.2 Ponatinib Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Ponatinib Revenue by Manufacturers (2014-2019)
- 3.2.2 Ponatinib Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Ponatinib Market Concentration Ratio (CR5 and HHI)
- 3.3 Ponatinib Price by Manufacturers
- 3.4 Key Manufacturers Ponatinib Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Ponatinib Market
- 3.6 Key Manufacturers Ponatinib Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 45mg Sales and Revenue (2014-2019)
- 4.1.2 15mg Sales and Revenue (2014-2019)
- 4.2 Global Ponatinib Sales Market Share by Type
- 4.3 Global Ponatinib Revenue Market Share by Type
- 4.4 Ponatinib Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Ponatinib Sales by Application
6 United States
- 6.1 United States Ponatinib Breakdown Data by Company
- 6.2 United States Ponatinib Breakdown Data by Type
- 6.3 United States Ponatinib Breakdown Data by Application
7 European Union
- 7.1 European Union Ponatinib Breakdown Data by Company
- 7.2 European Union Ponatinib Breakdown Data by Type
- 7.3 European Union Ponatinib Breakdown Data by Application
8 China
- 8.1 China Ponatinib Breakdown Data by Company
- 8.2 China Ponatinib Breakdown Data by Type
- 8.3 China Ponatinib Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Ponatinib Breakdown Data by Company
- 9.2 Rest of World Ponatinib Breakdown Data by Type
- 9.3 Rest of World Ponatinib Breakdown Data by Application
- 9.4 Rest of World Ponatinib Breakdown Data by Countries
- 9.4.1 Rest of World Ponatinib Sales by Countries
- 9.4.2 Rest of World Ponatinib Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 ARIAD Pharmaceuticals
- 10.1.1 ARIAD Pharmaceuticals Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Ponatinib
- 10.1.4 Ponatinib Product Introduction
- 10.1.5 ARIAD Pharmaceuticals Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Ponatinib Sales Channels
- 11.2.2 Ponatinib Distributors
- 11.3 Ponatinib Customers
12 Market Forecast
- 12.1 Global Ponatinib Sales and Revenue Forecast 2019-2025
- 12.2 Global Ponatinib Sales Forecast by Type
- 12.3 Global Ponatinib Sales Forecast by Application
- 12.4 Ponatinib Forecast by Regions
- 12.4.1 Global Ponatinib Sales Forecast by Regions 2019-2025
- 12.4.2 Global Ponatinib Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Ponatinib. Industry analysis & Market Report on Ponatinib is a syndicated market report, published as Global (United States, European Union and China) Ponatinib Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Ponatinib market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
